• Prophase Labs Inc PRPH.OQ reported a quarterly adjusted loss of 14 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -7 cents. The lone analyst forecast for the quarter was for a loss of 18 cents per share.

• Revenue fell 60.6% to $1.43 million from a year ago; analysts expected $2.45 million.

• Prophase Labs Inc shares had fallen by 20.7% this quarter and lost 57.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• Wall Street's median 12-month price target for Prophase Labs Inc is $16.00

This summary was machine generated from LSEG data May 20 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)